Skip to main content
Premium Trial:

Request an Annual Quote

Univ. of Southern Denmark Wins $10.7M for Omics, Computational Lab Infrastructure

NEW YORK (GenomeWeb News) – The University of Southern Denmark has reeled in an €8 million ($10.7 million) grant to create a research infrastructure for the school's Center for Bioanalytical Sciences, which will conduct genomics, proteomics, and lipidomics studies.

The funding from the Danish non-profit Villum Foundation will support the purchase of DNA sequencing and mass spectrometry technologies, imaging and biomolecular structure analysis tools, and computational and supercomputing platforms for large-scale data analyses.

The grant "provides us with new equipment to investigate complex biological systems, from individual biomolecules all the way to genomes, proteomes, and metabolomes and systems-wide studies," Ole Jensen, head of the university's biochemistry and molecular biology department, said in a statement.

Jensen said the grant will provide for a "very strong platform" for storing and integrating data and for computational modeling of biomolecules and cellular networks.

The Villum Foundation is the principal shareholder of VKR Holding, the parent company of the Velux Group and other businesses.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.